L'Oreal Loses Botox Trademark Fight In EU

Law360, New York (May 10, 2012, 12:54 PM EDT) -- The European Union's high court on Thursday struck down L'Oreal SA's attempt to trademark its Botocyl cosmetics treatment, finding the mark leeched off the reputation of competitor Allergan Inc.'s well-established Botox brand name.

The European Court of Justice ruling upholds two decisions by the EU trademark authority, the Office of Harmonization for the Internal Market, to annul marks on L'Oreal's Botocyl name and the Botolist brand name used by cosmetics maker Helena Rubinstein SNC, which is owned by L'Oreal.

The cases originated as separate EU General...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.